The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials
Open accessAbstract
BACKGROUND: Many placebo-controlled trials have demonstrated the efficacy of individual pharmacotherapies approved for smoking cessation. However, few direct or indirect comparisons of such interventions have been conducted. We performed a meta-analysis to compare the treatment effects of 7 approved pharmacologic interventions for smoking cessation. METHODS: We searched the US Centers for Disease Control and Prevention's Tobacco Information and Prevention database as well as MEDLINE, EMBASE and the Cochrane Library for published reports of placebo-controlled, double-blind randomized controlled trials of pharmacotherapies for smoking cessation. We included studies that reported biochemically validated measures of abstinence at 6 and 12 months. We used a hierarchical Bayesian random-effects model to summarize the results for each intervention. RESULTS: We identified 70 published reports of 69 trials involving a total of 32 908 patients. Six of the 7 pharmacotherapies studied were found to be more efficacious than placebo: varenicline (odds ratio [OR] 2.41, 95% credible interval [CrI] 1.91-3.12), nicotine nasal spray (OR 2.37, 95% CrI 1.12-5.13), bupropion (OR 2.07, 95% CrI 1.73-2.55), transdermal nicotine (OR 2.07, 95% CrI 1.69-2.62), nicotine tablet (OR 2.06, 95% CrI 1.12-5.13) and nicotine gum (OR 1.71, 95% CrI 1.35-2.21). Similar results were obtained regardless of which measure of abstinence was used. Although the point estimate favoured nicotine inhaler over placebo (OR 2.17), these results were not conclusive because the credible interval included unity (95% CrI 0.95-5.43). When all 7 interventions were included in the same model, all were more efficacious than placebo. In our analysis of data from the varenicline trials that included bupropion control arms, we found that varenicline was superior to bupropion (OR 2.18, 95% CrI 1.09-4.08). INTERPRETATION: Varenicline, bupropion and the 5 nicotine replacement therapies were all more efficacious than placebo at promoting smoking abstinence at 6 and 12 months.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710233371703 · Cited by 1,261
Antidepressants for smoking cessation
Hughes, Jr., Stead, L., & Lancaster, T. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031 · Cited by 681
Kitler, M. E. (2005) · International Journal of Pharmaceutical Medicine · doi:10.2165/00124363-200519040-00007 · Cited by 480
Nides, M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1561 · Cited by 390
Oncken, C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1571 · Cited by 380
Christen, A. (1991) · JAMA · doi:10.1001/jama.1991.03470220049025 · Cited by 297
A Double-Blind Trial of a 16-Hour Transdermal Nicotine Patch in Smoking Cessation
Tonnesen, P., Norregaard, J., Simonsen, K., & Säwe, U. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250503 · Cited by 295
Cited by
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“Technical remarks: Clinicians should use smoking cessation programs based on effective and evidence-based approaches to aid in smoking cessation and avoidance of secondhand smoke (538,539).”
BackgroundPharmacological interventions for smoking cessation: an overview and network meta-analysis
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009329.pub2 · Cited by 1,243
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
Ioannidis, J. P. A. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081086 · Cited by 716
Unemployment and Substance Use: A Review of the Literature (1990-2010)
Henkel, D. (2011) · Current Drug Abuse Reviewse · doi:10.2174/1874473711104010004 · Cited by 590
Evaluation of inconsistency in networks of interventions
Veroniki, A. A., Vasiliadis, H. S., Higgins, J. P., & Salanti, G. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys222 · Cited by 576
Avoidable global cancer deaths and total deaths from smoking
Jha, P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2703 · Cited by 522
Smoking and increased Alzheimer's disease risk: A review of potential mechanisms
Durazzo, T. C., Mattsson, N., Weiner, M. W., & Initiative, A. D. N. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.04.009 · Cited by 451
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
Précoma, D. B., Oliveira, G. M. M. D., Simão, A. F., Dutra, O. P., Coelho-Filho, O. R., Izar, M. C. D. O., Póvoa, R. M. D. S., Giuliano, I. D. C. B., Alencar Filho, A. C. D., Machado, C. A., et al. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190204 · Cited by 434
Baskerville, T. A., & Douglas, A. J. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00154.x · Cited by 377
Smoking and Chronic Obstructive Pulmonary Disease (COPD). Parallel Epidemics of the 21st Century
Laniado-Laborín, R. (2009) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph6010209 · Cited by 361
Liu, J., Davidson, E., Bhopal, R., White, M., Johnson, M., Netto, G., Deverill, M., & Sheikh, A. (2012) · Health Technology Assessment · doi:10.3310/hta16440 · Cited by 237
Baker, R. J., Mark, P. B., Patel, R. K., Stevens, K. K., & Palmer, N. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0553-2 · Cited by 211
Gifford, E. V., Kohlenberg, B. S., Hayes, S. C., Pierson, H. M., Piasecki, M. P., Antonuccio, D. O., & Palm, K. M. (2011) · Behavior Therapy · doi:10.1016/j.beth.2011.03.002 · Cited by 200
Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials
Mottillo, S., Filion, K. B., Bélisle, P., Joseph, L., Gervais, A., O'Loughlin, J., Paradis, G., Pihl, R., Pilote, L., Rinfret, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn552 · Cited by 171
Self-citationMills, E. J., Wu, P., Lockhart, I., Wilson, K., & Ebbert, J. O. (2010) · Tobacco Induced Diseases · doi:10.1186/1617-9625-8-8 · Cited by 166
Williams, J. M., Anthenelli, R. M., Morris, C. D., Treadow, J., Thompson, J. R., Yunis, C., & George, T. P. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07522 · Cited by 162
Suicidal Behavior and Depression in Smoking Cessation Treatments
Moore, T. J., Furberg, C. D., Glenmullen, J., Maltsberger, J. T., & Singh, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027016 · Cited by 150
Eisenberg, M. J., Hébert-Losier, A., Windle, S. B., Greenspoon, T., Brandys, T., Fülöp, T., Nguyen, T., Elkouri, S., Montigny, M., Wilderman, I., et al. (2020) · JAMA · doi:10.1001/jama.2020.18889 · Cited by 110
Self-citationSuissa, K., Larivière, J., Eisenberg, M. J., Eberg, M., Gore, G. C., Grad, R., Joseph, L., Reynier, P. M., & Filion, K. B. (2017) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002458 · Cited by 109
Self-citationCarim-Todd, L., Mitchell, S. H., & Oken, B. S. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.04.014 · Cited by 82
Adverse effects and tolerability of medications for the treatment of tobacco use and dependence
Hays, J. T., & Ebbert, J. O. (2010) · Drugs · doi:10.2165/11538190-000000000-00000 · Cited by 74
Sterling, L. H., Windle, S. B., Filion, K. B., Touma, L., & Eisenberg, M. J. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002849 · Cited by 70
Self-citationAlternative smoking cessation aids: a meta-analysis of randomized controlled trials
Tahiri, M., Mottillo, S., Joseph, L., Pilote, L., & Eisenberg, M. J. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.09.028 · Cited by 70
Self-citationLe Strat, Y., Rehm, J., & Le Foll, B. (2011) · Tobacco Control · doi:10.1136/tc.2010.038703 · Cited by 67
Roche, A. I., Kroska, E. B., & Denburg, N. L. (2019) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.06.002 · Cited by 41
McCann, D. J., & Li, S. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00263.x · Cited by 41
Bujarski, S., Roche, D. J. O., Sheets, E. S., Krull, J. L., Guzman, I., & Ray, L. A. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0038861 · Cited by 40
“These findings are consistent with the use of nicotine replacement therapies targeting withdrawal (Silagy, Mant, Fowler, & Lodge, 1994; Stead et al., 1996; Wu, Wilson, Dimoulas, & Mills, 2006) and antidepressants, such as bupropion (Dale et al., 2001; Eisenberg et al., 2008) among heavy smokers.”
Smoking cessation-recent advances
McNeil, J. J., Piccenna, L., & Ioannides-Demos, L. L. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6246-8 · Cited by 31
Cessation Among State Quitline Participants with a Mental Health Condition
Kerkvliet, J. L., Wey, H., & Fahrenwald, N. L. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu239 · Cited by 29
Predictors of the occurrence of smoking discontinuation in novice adolescent smokers
O'Loughlin, J. L., Sylvestre, M.-P., Dugas, E. N., & Karp, I. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0869 · Cited by 17
Self-citation
Metadata
- Authors
- Eisenberg, M. J., Filion, K. B., Yavin, D., Belisle, P., Mottillo, S., Joseph, L., Gervais, A., O'Loughlin, J., Paradis, G., Rinfret, S., & Pilote, L.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2008-07-15
- Volume
- 179
- Issue
- 2
- Pages
- 135-144
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W2166288613
- Cited by
- 318
- References
- 80
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.